CUSIP: 114082100
What is CUSIP 114082100?
CUSIP 114082100 identifies BTX - BROOKLYN IMMUNOTHERAPEUTICS - COM in SEC 13F datasets.
Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.
Open recent reporting periods for CUSIP 114082100:
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2022 Q4 | 0 | $0 | -$2,123,000 | 0 | |
| 2022 Q3 | 9,813,375 | $2,422,000 | -$2,412,065 | $0.25 | 29 |
| 2022 Q2 | 15,186,440 | $7,859,000 | -$2,827,937 | $0.52 | 34 |
| 2022 Q1 | 18,679,007 | $38,292,000 | +$12,358,397 | $2.05 | 57 |
| 2021 Q4 | 12,485,518 | $52,120,000 | +$24,216,590 | $4.17 | 53 |
| 2021 Q3 | 4,802,205 | $44,865,569 | +$7,401,008 | $9.30 | 50 |
| 2021 Q2 | 4,241,481 | $76,391,577 | +$75,365,412 | $18.01 | 40 |
| 2021 Q1 | 102,346 | $380,000 | +$380,000 | $3.71 | 9 |